BioWorld MedTech

July 26, 2016

Tso3's Sterizone seen as revolutionary weapon in the treatment of superbugs, other bacteria

Canada's Tso3 Inc. has won expanded FDA clearance for its Sterizone VP4 sterilizer making it the only company validated to completely sterilize large, complex and hard-to-clean medical instruments, said company CEO Ric Rumble. Read More

Co-development of companion diagnostics raises unanswered guidance questions

Zimmer's India push aims to meet growing orthopedic needs

Aiming for turnaround,Zosano presses ahead in pivotal migraine trial

Technology 'focused' on destroying prostate cancer gaining traction in U.S.

Other news to note

Product briefs

Financings

Appointments and advancements

MDD's Cardiology Extra

Today's news in brief

BioWorld

BioWorld briefs for April 4, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 4, 2025.

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

3D rendering of glucagon-like peptide 1 (GLP-1)

ADPD 2025: Unlocking GLP-1's potential in neurodegeneration

BioWorld

At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...

Immune checkpoint inhibitors illustration of PD-1, CTLA-4 and PD-L1.

Checkpoint inhibitor journey traces Chinese firms’ path to global revenue

BioWorld

Chinese pharmaceutical companies are making significant inroads into the global oncology market, particularly with the development and approval of immune...